Abstract The effect of the new immunomodulating synthetic dipeptide pidotimod on some human immune functions was studied after ex vivo administration in healthy elderly subjects, as a model of acquired immune deficit. Results showed that treatment with pidotimod enhanced mitogen-induced lymphocyte proliferation and γ-IFN production. The drug slightly reduced IL-6 content in supernatants from adherent monocytes, while it did not significantly affect polyclonal Ig synthesis. These findings further support the biological response modifying activity of pidotimod in human subjects

Ex vivo effect of pidotimod on peripheral blood mononuclear cell immune functions: Study of an elderly population

NICOLETTI, FERDINANDO;
1994-01-01

Abstract

Abstract The effect of the new immunomodulating synthetic dipeptide pidotimod on some human immune functions was studied after ex vivo administration in healthy elderly subjects, as a model of acquired immune deficit. Results showed that treatment with pidotimod enhanced mitogen-induced lymphocyte proliferation and γ-IFN production. The drug slightly reduced IL-6 content in supernatants from adherent monocytes, while it did not significantly affect polyclonal Ig synthesis. These findings further support the biological response modifying activity of pidotimod in human subjects
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11769/58257
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact